Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIK | AZN | AMGN | GILD | BMY |
| Company | Anika Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 14.85 | 184.36 | 326.03 | 130.44 | 57.65 |
| High | 15.21 | 185.19 | 326.79 | 132.89 | 58.00 |
| Low | 14.69 | 183.78 | 323.21 | 130.00 | 56.93 |
| Latest | 14.79 | 184.73 | 324.15 | 132.08 | 57.23 |
| Change | -0.06 | -0.01 | -5.67 | +0.43 | -0.99 |
| % Change | -0.40% | -0.01% | -1.72% | +0.33% | -1.70% |
| Volume | 38,487 | 257,756 | 524,031 | 1,459,376 | 2,351,958 |
| 20-Day Average Volume | 133,020 | 1,971,006 | 2,472,138 | 5,214,870 | 9,551,478 |
| Previous Close | 14.85 | 184.74 | 329.82 | 131.65 | 58.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.99 | 195.85 | 345.15 | 135.19 | 58.65 |
| 20-Day Raw Stochastic | 65.74% | 12.47% | 3.07% | 31.96% | 9.87% |
| 20-Day Relative Strength | 52.39 | 39.78 | 36.16 | 43.00 | 45.71 |
| Weighted Alpha | +32.92 | +29.44 | +15.41 | +28.91 | +23.77 |
| Today's Opinion | 72% Buy | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 72% Buy | 24% Buy | 8% Sell | 8% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.88% since 04/27/26 | -1.38% since 04/27/26 | -4.51% since 04/27/26 | +3.75% since 04/27/26 | -0.81% since 04/27/26 |
| Low | 11.92 on 04/30/26 | 181.73 on 04/29/26 | 323.75 on 05/04/26 | 127.96 on 04/30/26 | 56.93 on 05/04/26 |
| High | 15.98 on 04/28/26 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 132.89 on 05/04/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | -0.27% since 04/02/26 | -9.13% since 04/02/26 | -6.64% since 04/02/26 | -5.13% since 04/02/26 | -3.84% since 04/02/26 |
| Low | 11.92 on 04/30/26 | 181.73 on 04/29/26 | 323.75 on 05/04/26 | 127.64 on 04/27/26 | 56.93 on 05/04/26 |
| High | 16.24 on 04/20/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +38.33% since 02/04/26 | -1.35% since 02/04/26 | -11.29% since 02/04/26 | -9.36% since 02/04/26 | -0.54% since 02/04/26 |
| Low | 9.88 on 02/13/26 | 181.73 on 04/29/26 | 323.75 on 05/04/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 16.24 on 04/20/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +53.27% since 11/04/25 | +12.71% since 11/04/25 | +9.49% since 11/04/25 | +7.76% since 11/04/25 | +25.71% since 11/04/25 |
| Low | 9.01 on 01/28/26 | 162.04 on 11/05/25 | 302.13 on 11/05/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 16.24 on 04/20/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 197,594 | 286,514,752 | 177,998,896 | 163,406,864 | 118,869,808 |
| Shares Outstanding, K | 13,306 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 112,820,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -10,880,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 30,620,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 290,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.16 | 0.26 | 0.44 | 0.32 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.27 on 04/29/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 07/29/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.67 | 16.05 | 10.22 |